Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care

Renin‐angiotensin‐aldosterone system inhibitors (RAASi) are recommended for chronic kidney disease (CKD) patients. In this study, we describe RAASi prescription patterns in the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) in Brazil, Germany, France, and the United States (US...

Descripción completa

Detalles Bibliográficos
Autores principales: Pecoits‐Filho, Roberto, Fliser, Danilo, Tu, Charlotte, Zee, Jarcy, Bieber, Brian, Wong, Michelle M. Y., Port, Friedrich, Combe, Christian, Lopes, Antonio A., Reichel, Helmut, Narita, Ichiei, Stengel, Benedicte, Robinson, Bruce M., Massy, Ziad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Kidney
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771881/
https://www.ncbi.nlm.nih.gov/pubmed/31169352
http://dx.doi.org/10.1111/jch.13563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771881/
https://www.ncbi.nlm.nih.gov/pubmed/31169352
http://dx.doi.org/10.1111/jch.13563

Ejemplares similares